RHYTHM PHARMACEUTICALS, INC.

Pharmaceutical Preparations·BOSTON, MA·FY end 12/31·CIK 1649904

Overview Financials Compensation Governance Insiders Filings

Named Executive Officers

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
David P. MeekerChief Executive Officer	$807.7K	$8.3M	$7.7M	$759.5K	$14.0K	$17.5M
Hunter C. SmithChief Financial Officer	$540.5K	$2.9M	$2.4M	$338.0K	$14.0K	$6.2M
Yann MazabraudExecutive Vice President,	$557.2K	$2.8M	$2.3M	$344.7K	$70.3K	$6.1M
Jennifer LeeExecutive Vice President,	$531.6K	$2.6M	$2.1M	$293.0K	$14.0K	$5.6M
Alastair GarfieldChief Scientific Officer	$505.4K	$2.1M	$1.5M	$287.0K	$14.0K	$4.4M

CEO pay mix

David P. Meeker · FY 2025

Stock awards$8.3M47%

Performance bonus$759.5K4%

Salary$807.7K5%

Other$7.7M44%

Performance vs. pay

Item 402(v) Pay-Versus-Performance disclosure data not yet ingested for this company. Mandatory only for FYs ending on/after Dec 16, 2022 — older companies may not have filed it yet.

CEO comp · median worker · ratio — 5-year trend

CEO total compMedian employeePay ratio (right axis)